galantamine hydrobromide 16 MG 24 HR Extended Release Oral Capsule

RxCUI
860695
RxNorm name
galantamine hydrobromide 16 MG 24 HR Extended Release Oral Capsule
Display name
galantamine hydrobromide 16 MG 24 HR Extended Release Oral Capsule
Full name
galantamine hydrobromide 16 MG 24 HR Extended Release Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Galantamine HydrobromideGALANTAMINE HYDROBROMIDEBryant Ranch Prepack3059d10f-fb3d-4cbd-b936-104608889b672024-08-12Warnings, Adverse reactionsExact identifier
rxcui: 860695
Galantamine HydrobromideGALANTAMINE HYDROBROMIDEBryant Ranch Prepack5cd99bc0-0f18-4800-a0f5-a94eebf0eead2024-04-08Warnings, Adverse reactionsExact identifier
rxcui: 860695
GalantamineGALANTAMINEAurobindo Pharma Limitedd0b75970-8d3d-408b-9e17-9cbad0f776b12024-01-30Warnings, Adverse reactionsExact identifier
rxcui: 860695
Galantamine HydrobromideGALANTAMINE HYDROBROMIDESun Pharmaceutical Industries, Inc.d1697161-ebe8-42b0-83e7-c9de4412546c2023-10-26Warnings, Adverse reactionsExact identifier
rxcui: 860695

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3059d10f-fb3d-4cbd-b936-104608889b67galantamine HBr 16 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR galantamine hydrobromide 16 MG Extended Release Oral Capsule [SCD] · galantamine hydrobromide 16 MG 24 HR Extended Release Oral Capsule [SY]3105These highlights do not include all the information needed to use GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES. GALANTAMINE HYDROBROMIDE extended-release capsules, for oral use Initial U.S. Approval: 200120240812
5cd99bc0-0f18-4800-a0f5-a94eebf0eeadgalantamine HBr 16 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR galantamine hydrobromide 16 MG Extended Release Oral Capsule [SCD] · galantamine hydrobromide 16 MG 24 HR Extended Release Oral Capsule [SY]3101These highlights do not include all the information needed to use GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES. GALANTAMINE HYDROBROMIDE extended-release capsules, for oral use Initial U.S. Approval: 200120240408
d1697161-ebe8-42b0-83e7-c9de4412546cgalantamine HBr 16 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR galantamine hydrobromide 16 MG Extended Release Oral Capsule [SCD] · galantamine hydrobromide 16 MG 24 HR Extended Release Oral Capsule [SY]317These highlights do not include all the information needed to use GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for GALANTAMINE HYDROBROMIDE EXTENDED-RELEASE CAPSULES. GALANTAMINE HYDROBROMIDE extended-release capsules, for oral use Initial U.S. Approval: 200120231026
d0b75970-8d3d-408b-9e17-9cbad0f776b1galantamine HBr 16 MG 24HR Extended Release Oral Capsule [PSN] · 24 HR galantamine hydrobromide 16 MG Extended Release Oral Capsule [SCD] · galantamine hydrobromide 16 MG 24 HR Extended Release Oral Capsule [SY]311These highlights do not include all the information needed to use GALANTAMINE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for GALANTAMINE EXTENDED-RELEASE CAPSULES. GALANTAMINE extended-release capsules, for oral use Initial U.S. Approval: 200120240130